Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines.

Standard

Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. / Schmöcker, Christoph; Weylandt, Karsten H; Kahlke, Lena; Wang, Jingdong; Lobeck, Hartmut; Tiegs, Gisa; Berg, Thomas; Kang, Jing X.

In: HEPATOLOGY, Vol. 45, No. 4, 4, 2007, p. 864-869.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schmöcker, C, Weylandt, KH, Kahlke, L, Wang, J, Lobeck, H, Tiegs, G, Berg, T & Kang, JX 2007, 'Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines.', HEPATOLOGY, vol. 45, no. 4, 4, pp. 864-869. <http://www.ncbi.nlm.nih.gov/pubmed/17393517?dopt=Citation>

APA

Schmöcker, C., Weylandt, K. H., Kahlke, L., Wang, J., Lobeck, H., Tiegs, G., Berg, T., & Kang, J. X. (2007). Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. HEPATOLOGY, 45(4), 864-869. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17393517?dopt=Citation

Vancouver

Schmöcker C, Weylandt KH, Kahlke L, Wang J, Lobeck H, Tiegs G et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. HEPATOLOGY. 2007;45(4):864-869. 4.

Bibtex

@article{c050f4fcfdd148438831544871ddc79f,
title = "Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines.",
abstract = "Cytokines such as tumor necrosis factor alpha (TNF-alpha) are key factors in liver inflammation. Supplementation with essential omega-3 polyunsaturated fatty acids (n-3 PUFA) has been demonstrated to lower TNF-alpha and IL-1 production in mononuclear cells. An inflammation-dampening effect has been observed with increased omega-3 fatty acid supplementation in several inflammatory diseases. In this study, we used the transgenic fat-1 mouse, expressing a Caenorhabditis elegans desaturase endogenously forming n-3 PUFA from n-6 PUFA, to analyze the effect of an increased n-3 PUFA tissue status in the macrophage-dependent acute D-galactosamine/lipopolysaccaride (D-GalN/LPS) hepatitis model. We show less severe inflammatory liver injury in fat-1 mice with a balanced n-6/n-3 PUFA ratio as evidenced by reduced serum alanine aminotransferase levels and less severe histological liver damage. This decreased inflammatory response was associated with decreased plasma TNF-alpha levels and with reduced hepatic gene expression of TNF-alpha, IL-1beta, IFN-gamma and IL-6 in fat-1 mice, leading to a decreased rate of apoptosis in livers from fat-1 animals, as measured by DAPI-staining. CONCLUSION: The results of this study offer evidence for an inflammation dampening effect of omega-3 polyunsaturated fatty acids in the context of liver inflammation.",
author = "Christoph Schm{\"o}cker and Weylandt, {Karsten H} and Lena Kahlke and Jingdong Wang and Hartmut Lobeck and Gisa Tiegs and Thomas Berg and Kang, {Jing X}",
year = "2007",
language = "Deutsch",
volume = "45",
pages = "864--869",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines.

AU - Schmöcker, Christoph

AU - Weylandt, Karsten H

AU - Kahlke, Lena

AU - Wang, Jingdong

AU - Lobeck, Hartmut

AU - Tiegs, Gisa

AU - Berg, Thomas

AU - Kang, Jing X

PY - 2007

Y1 - 2007

N2 - Cytokines such as tumor necrosis factor alpha (TNF-alpha) are key factors in liver inflammation. Supplementation with essential omega-3 polyunsaturated fatty acids (n-3 PUFA) has been demonstrated to lower TNF-alpha and IL-1 production in mononuclear cells. An inflammation-dampening effect has been observed with increased omega-3 fatty acid supplementation in several inflammatory diseases. In this study, we used the transgenic fat-1 mouse, expressing a Caenorhabditis elegans desaturase endogenously forming n-3 PUFA from n-6 PUFA, to analyze the effect of an increased n-3 PUFA tissue status in the macrophage-dependent acute D-galactosamine/lipopolysaccaride (D-GalN/LPS) hepatitis model. We show less severe inflammatory liver injury in fat-1 mice with a balanced n-6/n-3 PUFA ratio as evidenced by reduced serum alanine aminotransferase levels and less severe histological liver damage. This decreased inflammatory response was associated with decreased plasma TNF-alpha levels and with reduced hepatic gene expression of TNF-alpha, IL-1beta, IFN-gamma and IL-6 in fat-1 mice, leading to a decreased rate of apoptosis in livers from fat-1 animals, as measured by DAPI-staining. CONCLUSION: The results of this study offer evidence for an inflammation dampening effect of omega-3 polyunsaturated fatty acids in the context of liver inflammation.

AB - Cytokines such as tumor necrosis factor alpha (TNF-alpha) are key factors in liver inflammation. Supplementation with essential omega-3 polyunsaturated fatty acids (n-3 PUFA) has been demonstrated to lower TNF-alpha and IL-1 production in mononuclear cells. An inflammation-dampening effect has been observed with increased omega-3 fatty acid supplementation in several inflammatory diseases. In this study, we used the transgenic fat-1 mouse, expressing a Caenorhabditis elegans desaturase endogenously forming n-3 PUFA from n-6 PUFA, to analyze the effect of an increased n-3 PUFA tissue status in the macrophage-dependent acute D-galactosamine/lipopolysaccaride (D-GalN/LPS) hepatitis model. We show less severe inflammatory liver injury in fat-1 mice with a balanced n-6/n-3 PUFA ratio as evidenced by reduced serum alanine aminotransferase levels and less severe histological liver damage. This decreased inflammatory response was associated with decreased plasma TNF-alpha levels and with reduced hepatic gene expression of TNF-alpha, IL-1beta, IFN-gamma and IL-6 in fat-1 mice, leading to a decreased rate of apoptosis in livers from fat-1 animals, as measured by DAPI-staining. CONCLUSION: The results of this study offer evidence for an inflammation dampening effect of omega-3 polyunsaturated fatty acids in the context of liver inflammation.

M3 - SCORING: Zeitschriftenaufsatz

VL - 45

SP - 864

EP - 869

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 4

M1 - 4

ER -